-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Recursion Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2019 to 2024.
- Recursion Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending December 31, 2024 was $30.3M, a 93.2% increase year-over-year.
- Recursion Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2024 was $79.5M, a 53.8% increase year-over-year.
- Recursion Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $79.5M, a 53.8% increase from 2023.
- Recursion Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $51.7M, a 92.3% increase from 2022.
- Recursion Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $26.9M, a 94.3% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)